Pharvaris (NASDAQ: PHVS) Soars on Positive HAE Drug Trial Results and Oppenheimer Price Target Hike
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameHaemonetics Corporation
-
Registration countryUSA
-
IndustryMedical Devices
-
М/S&P/F
*** /*** /***









